Italy Ultrasound Devices Market Analysis by Mordor Intelligence
The Italy Ultrasound Devices Market size is estimated at USD 278.58 million in 2025, and is expected to reach USD 343.68 million by 2030, at a CAGR of 4.29% during the forecast period (2025-2030).
The steady up-trend reflects the National Recovery and Resilience Plan (NRRP) budget allocation for replacing obsolete imaging equipment, the country’s status as Europe’s fourth-largest medical-device marketplace, and continued public-hospital dominance in procurement. Rising chronic-disease prevalence, rapid adoption of 3D/4D imaging, and an ongoing pivot to handheld point-of-care systems add further momentum, while EU MDR compliance costs and regional budget constraints temper the growth trajectory. Manufacturers concentrate on AI-enabled workflow tools that mitigate Italy’s sonographer shortage, and on flexible financing models that help Southern regions bridge the North–South technology gap. Competitive advantage increasingly stems from end-to-end service contracts and cross-modality software suites that can be deployed quickly under time-bound NRRP tenders.
Key Report Takeaways
- By application, radiology led with 38.13% of Italy ultrasound devices market share in 2024, whereas critical care is advancing at a 5.83% CAGR through 2030.
- By technology, 3D & 4D imaging commanded 41.87% of the Italy ultrasound devices market size in 2024, while HIFU is projected to expand at a 5.33% CAGR between 2025-2030.
- By portability, stationary systems captured 62.47% share of the Italy ultrasound devices market size in 2024; handheld units record the highest projected CAGR at 7.18% through 2030.
- By end user, hospitals held 54.64% of the Italy ultrasound devices market share in 2024, while home-health settings are forecast to grow at a 6.68% CAGR to 2030.
Italy Ultrasound Devices Market Trends and Insights
Drivers Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Increasing burden of chronic diseases | +0.8% | National — higher in North | Long term (≥ 4 years) |
| Technological advancements in imaging & AI | +1.2% | National — early adopters in major centers | Medium term (2-4 years) |
| NRRP funding for obsolete-equipment renewal | +0.9% | National — priority for South | Short term (≤ 2 years) |
| Post-COVID shift to handheld/POC ultrasound | +0.7% | National — ICU & ED focus | Medium term (2-4 years) |
| Centralized procurement & e-tender reform | +0.4% | National | Long term (≥ 4 years) |
| Growth in ultrasound-guided pain procedures | +0.5% | National — specialty centers | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Increasing Burden of Chronic Diseases
Italy’s aging profile 23.5% of residents are over 65 creates rising cardiovascular, musculoskeletal, and oncological screening needs that rely on ultrasound for first-line imaging. Hospital networks respond by prioritizing multi-application consoles that support cardiology, vascular, and abdominal exams within a single workflow, reinforcing capital demand in both tertiary and community hospitals. Handheld scanners are now embedded in chronic-care home-visits conducted by family physicians, reducing unnecessary travel for mobility-limited patients. Northern regions fund advanced 3D/4D units for complex cardiac follow-up, while Southern provinces channel NRRP grants toward baseline 2D systems to close diagnostic-access gaps. The predictable rise in chronic-care visits provides stable replacement cycles for vendors and underpins multi-year service contracts that guarantee uptime and staff training.
Technological Advancements in Imaging & AI
Research groups in Rome, Milan, and Bologna have validated convolutional-neural-network algorithms that auto-classify obstetric, musculoskeletal, and thyroid scans with 94-96% accuracy, cutting exam times by 28%.[1]Università Cattolica del Sacro Cuore, “AI-Guided Obstetric Ultrasound Project,” unicatt.it AI overlay is now embedded in premium consoles as an optional license, giving hospitals a modular upgrade path that circumvents full hardware replacement. Cloud-based decision-support dashboards enable remote over-reads by sub-specialists, a critical aid to smaller Southern facilities that lack experienced sonographers. Competitive tender documents increasingly include real-time quality-assurance metrics, pushing vendors to bundle AI software and standardized reporting templates. While reimbursement still applies to the scan and not the algorithm, early adopters leverage faster throughput to raise monthly exam volumes without adding staff.
NRRP Funding for Replacement of Obsolete Equipment
Between 2024-2026, regional health authorities will disburse EUR 1.18 (USD 1.37) billion for imaging-equipment upgrades, with ultrasound explicitly listed among priority assets. Procurement guidelines favor products that ship within 120 days and include on-site training, encouraging manufacturers to maintain Italian warehousing hubs. Southern tenders bundle stationary carts with at least two portable units per hub-and-spoke network, creating sudden scale for handheld-device orders. Volume purchasing compresses average selling prices by up to 12%, yet service and software annuities offset hardware margin erosion. Vendors able to certify devices under EU MDR before the 2027 grace deadline enjoy a bidding advantage, as regions avoid platforms that might face post-market withdrawal.
Post-COVID Shift to Handheld/POC Ultrasound
ICU protocols introduced in 2020 now mandate lung ultrasound scoring at admission and discharge for COVID and non-COVID respiratory cases alike, institutionalizing bedside imaging.[2]European Society of Cardiology, “Post-COVID Bedside Imaging Protocols,” escardio.org The Italian Society of Emergency Medicine reports that 88% of EDs stock at least one handheld unit, up from 42% pre-pandemic. Device carts equipped with single-use probe sheaths streamline infection control, and rechargeable batteries lasting a full shift minimize room-entry frequency. Tele-ultrasound platforms allow remote intensivists to supervise novice operators in real time, an important safeguard in smaller Southern hospitals. The behavioral shift spreads to ambulatory cardiology clinics, where pocket devices perform routine ejection-fraction checks, smoothing patient flow and reducing scheduling backlogs.
Restraints Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| EU MDR & stringent local regulations | -0.6% | National — hardest on SMEs | Long term (≥ 4 years) |
| High cost of advanced cart & HIFU systems | -0.4% | National — stronger in South | Medium term (2-4 years) |
| Limited outpatient reimbursement tariffs | -0.3% | National — varies by region | Long term (≥ 4 years) |
| Shortage of trained sonographers in South | -0.5% | Southern regions | Long term (≥ 4 years) |
| Source: Mordor Intelligence | |||
EU MDR & Stringent Local Regulations
Certification queues at notified bodies extend device-launch lead times from 9 to 18 months, forcing several SMEs to freeze R&D pipelines or withdraw low-volume probes.[3]European Commission, “MDR Transition Guidance,” europa.eu Italian language-labeling and post-market surveillance updates add roughly EUR 120 thousands (USD 139 thousands) per product family, a heavy outlay for niche HIFU firms. Hospitals, wary of mid-cycle de-certification, stipulate MDR compliance as a hard tender requirement, effectively sidelining legacy CE-marked models. Larger multinationals absorb the cost by amortizing across global volumes, increasing their competitive edge. While the new rules raise clinical-evidence standards, they also suppress the pace at which novel transducers or AI modules reach clinicians, moderating near-term growth.
High Cost of Advanced Cart & HIFU Systems
Premium 3D/4D consoles list above EUR 120,000 (USD 135,700) and HIFU suites exceed EUR 1 million (USD 1.13 million), straining hospital budgets already facing a 5% cap on annual capital outlays. The payback levy obliges vendors to refund part of public spending overruns, limiting room for discounting. Southern regions, which allocate a higher share of budgets to staffing and basic infrastructure, postpone high-end upgrades and favor refurbished 2D units. Financing innovations—operating leases and pay-per-scan models—appear, yet uptake remains slow because accounting rules still classify them as debt. Consequently, HIFU expansion is largely confined to research hospitals and private cancer centers in the North and Center, curbing nationwide therapeutic-ultrasound penetration.
Segment Analysis
By Application: Radiology Remains Foundational While Critical-Care Usage Surges
Radiology commands 38.13% of Italy ultrasound devices market share, capitalizing on consolidated hospital imaging budgets and workflow-optimization software that routes referrals electronically. Multi-disciplinary reliance from oncology staging to abdominal emergencies anchors recurring probe-replacement demand and raises console utilization rates above 80% in tertiary centers. Gynecology/obstetrics sustains volume with three state-funded prenatal scans, and private clinics often add early-pregnancy 3D packages. Cardiology exploits handheld echocardiography for rapid triage, boosting outpatient throughput and reducing unnecessary CT scans.
Critical care, advancing at a 5.83% CAGR, benefits from protocolized lung, vascular-access, and cardiac-function assessments at the bedside. Clinical-engineering departments, intent on standardizing device fleets, increasingly favor cross-department consoles equipped with preset ICU, ED, and anesthesia workflows. Radiology departments, in turn, extend their influence by training non-radiologist clinicians and overseeing PACS integration, thereby preserving governance over rising point-of-care volumes.
Note: Segment shares of all individual segments available upon report purchase
By Technology: 3D/4D Dominance Meets HIFU Momentum
3D & 4D platforms hold 41.87% of Italy ultrasound devices market share thanks to high-resolution volumetric rendering that enhances obstetric bonding and guides complex cardiac interventions. Integrated elastography modules add incremental liver-disease value and reduce MRI referrals. Doppler suites remain standard on upper-mid carts, supporting carotid-plaque and peripheral-artery monitoring in aging populations.
HIFU, the fastest-growing technology at 5.33% CAGR, gains traction in prostate, uterine-fibroid, and bone-metastasis indications after multi-center studies in Turin and Bologna reported pain-reduction rates above 60% at six months. Funding flows from mixed public-private partnerships, while manufacturers provide clinical-project management and physician training to accelerate adoption. The tilt toward therapeutic ultrasound encourages vendors to bundle diagnostic consoles with a path to future HIFU upgrades, locking in long-term customer relationships.
By Portability: Stationary Carts Anchor Workflows, Handhelds Outpace
Stationary systems account for 62.47% of Italy ultrasound devices market size, as hospitals rely on high-bandwidth GPUs, broad probe portfolios, and dual-user interfaces that support teaching requirements. Central-sterile tracking features integrate with hospital IT, easing MDR traceability. Portable carts gain favor in emergency units where admission volume spikes demand rapid turnover; wheels, integrated batteries, and rugged shells suit corridor environments.
Handheld devices, projected at a 7.18% CAGR, weigh under 300 g, connect to smartphones, and upload images directly to regional PACS clouds. Italian telemedicine pilots in Calabria and Sardinia deploy these units for cardiology and abdominal screening during home visits, cutting patient-travel subsidies by 15% within one year. Integration hurdles Wi-Fi security, DICOM compatibility—are shrinking as vendors release API toolkits certified for national e-health platforms.
Note: Segment shares of all individual segments available upon report purchase
By End User: Hospitals Lead But Home-Healthcare Adoption Accelerates
Hospitals control 54.64% Italy ultrasound devices market share, driven by volume-based procurement and bundled service contracts that run five to seven years. Academic centers attract vendor-supported research and early-adopter discounts, while non-teaching provincial hospitals opt for mid-range consoles to contain capital intensity. Diagnostic imaging centers thrive in metropolitan areas where private insurance and co-pay models expedite patient access to advanced scans.
Home-healthcare, expanding at 6.68% CAGR, tackles Italy’s projected 1.4 million additional over-80 residents by 2030. Regional authorities reimburse portable-scan visits that prevent unplanned admissions, and family doctors receive cloud-based dashboards to flag abnormal findings. Ambulatory surgical centers increasingly integrate intraoperative ultrasound for nerve blocks and same-day orthopedic repairs, supporting shorter lengths of stay and higher bed-turnover efficiencies.
Geography Analysis
Northern regions contribute major share of national ultrasound revenues thanks to higher GDP per capita, denser hospital networks, and strong private-sector penetration. Lombardy alone operates more than 1,400 ultrasound rooms, many linked to academic centers that trial AI and elastography plug-ins. Equipment-replacement cycles average five years, sustaining a predictable upgrade pipeline that favors premium platforms.
Central Italy combines public-policy leadership with mid-level technology budgets. Tuscany’s performance-evaluation system ties procurement funds to clinical-outcome metrics, resulting in earlier retirement of outdated scanners and quicker adoption of AI workflow add-ons. Lazio benefits from national-ministry proximity; hospitals in Rome secure pilot funding for tele-ultrasound networks that connect suburban clinics, reducing patient congestion in tertiary facilities.
Southern regions confront staffing gaps and longer device lifespans that can exceed nine years. NRRP investments earmark EUR 500 (USD 582.8) million for South-based imaging upgrades, spurring aggregated tenders that bundle consoles, handhelds, and five-year maintenance into single contracts. Mobile diagnostic vans equipped with solar-powered handheld probes now serve rural Calabria and Sicily, improving prenatal-care adherence by 18% in 2024 versus 2023. Vendors that station service engineers locally and provide structured sonographer training gain a decisive bidding edge.
Competitive Landscape
Italy exhibits moderate concentration: the top five vendors command significant share revenue, led by Esaote, GE Healthcare, Philips, Siemens Healthineers, and Canon Medical. Esaote’s 2023 turnover rose 6.5% to EUR 273.2 (USD 273.2) million, with ultrasound up 9.7% on the MyLab X90 launcH. Multinationals leverage global R&D scale, yet local customization Italian language interfaces, MDR documentation, and field-service density remains critical.
AI start-ups partner with incumbent hardware firms to embed cloud analytics, while consumer-electronics entrants test smartphone-tethered probes. EU MDR compliance favors established firms owning large post-market-surveillance teams, causing smaller importers to exit or private-label under larger distributors. Price competition eases in high-acuity segments as hospitals award bundled contracts that cover installation, staff certification, and five-year uptime guarantees, shifting focus from upfront capex to lifecycle value.
Strategic moves in 2024-2025 include Philips rolling out a no-interest leasing plan tailored to NRRP budgets, GE Healthcare adding Lombardy-based AI algorithm libraries to its LOGIQ portfolio, and Siemens Healthineers integrating its ultrasound consoles with the company’s CT-guided planning software to streamline oncology workflows. Local manufacturing incentives in Genoa and Florence support Esaote’s supply-chain resilience and reinforce its home-market foothold.
Italy Ultrasound Devices Industry Leaders
-
Canon Medical Systems Corporation
-
Fujifilm Holdings Corporation
-
GE Healthcare
-
Siemens Healthineers AG
-
Koninklijke Philips N.V.
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- November 2024: The Catholic University of Rome announced the development of AI-based ultrasound software for childbirth decisions, achieving 94.5% accuracy in determining delivery methods and expected availability in delivery rooms by 2028, representing a significant advancement in obstetric care technology
- January 2024: Esaote, one of the leading Italian companies in medical imaging participated in Arab Health and launched two new ultrasound systems namely MyLabA50 and MyLab A7.
Italy Ultrasound Devices Market Report Scope
A diagnostic ultrasound, also known as sonography, is an imaging technique that uses high-frequency sound waves to produce images of the different structures inside the body. They are being utilized for the assessment of various conditions in the kidney, liver, and other abdominal conditions. They are also widely used to treat chronic illnesses, which include ailments including diabetes, asthma, cancer, and heart disease. As a result, these devices have a variety of uses in the medical area, including both diagnostic imaging and therapeutic modality.
Italy's ultrasound devices market is segmented by application, technology and Type. By application, the market is segmented into anesthesiology, cardiology, gynecology/obstetrics, musculoskeletal, radiology, critical care, and other applications. By technology, market is segmented into 2D ultrasound imaging, 3D and 4D ultrasound imaging, doppler imaging, and high-intensity focused ultrasound. By type, market is segmented into stationary ultrasound and portable ultrasound.
The report offers the value (in USD) for the above segments.
| Anesthesiology |
| Cardiology |
| Gynecology / Obstetrics |
| Musculoskeletal |
| Radiology |
| Critical Care |
| Urology |
| Vascular |
| Other Applications |
| 2D Ultrasound Imaging |
| 3D & 4D Ultrasound Imaging |
| Doppler Imaging |
| High-Intensity Focused Ultrasound |
| Other Technologies |
| Stationary Systems |
| Portable Cart-based Systems |
| Hand-held / Pocket Devices |
| Hospitals |
| Diagnostic Centers |
| Ambulatory Surgical Centers |
| Home Healthcare Settings |
| Other End Users |
| By Application | Anesthesiology |
| Cardiology | |
| Gynecology / Obstetrics | |
| Musculoskeletal | |
| Radiology | |
| Critical Care | |
| Urology | |
| Vascular | |
| Other Applications | |
| By Technology | 2D Ultrasound Imaging |
| 3D & 4D Ultrasound Imaging | |
| Doppler Imaging | |
| High-Intensity Focused Ultrasound | |
| Other Technologies | |
| By Portability | Stationary Systems |
| Portable Cart-based Systems | |
| Hand-held / Pocket Devices | |
| By End User | Hospitals |
| Diagnostic Centers | |
| Ambulatory Surgical Centers | |
| Home Healthcare Settings | |
| Other End Users |
Key Questions Answered in the Report
What is the current value of the Italy ultrasound devices market?
The Italy ultrasound devices market is valued at USD 278.58 million in 2025.
How fast is the market expected to grow?
Revenue is projected to rise at a 4.29% CAGR, reaching USD 343.68 million by 2030.
Which application area contributes the most revenue?
Radiology leads with 38.13% share, reflecting its central role in hospital imaging workflows.
What technology segment is expanding the fastest?
High-intensity Focused Ultrasound (HIFU) is forecast to grow at a 5.33% CAGR through 2030.
Why are handheld ultrasound devices gaining traction?
Post-COVID safety protocols and NRRP digital-health initiatives drive 7.18% CAGR growth for handheld units by improving bedside and home-care diagnostics.
Page last updated on: